Omixon Launches NanoTYPE^TM RUO, a Multiplex Human Leukocyte Antigen Amplification kit compatible with Oxford Nanopore’s MinION^TM Platform and Enters into an Agreement with Oxford Nanopore Technologies

26/09/2022

High resolution histocompatibility testing for urgent transplant cases made possible within five hours turnaround time. Budapest, Hungary, September 27, 2022. Omixon Biocomputing, Ltd announced today the launch of NanoTYPE^TMRUO, a multiplex 11 loci human leukocyte antigen (HLA) amplification kit and the complementary NanoTYPER^TMsoftware compatible with Oxford Nanopore’s...

Editorial Board Award – Human Immunology

10/05/2022

Each year, the Human Immunology editorial board awards the best original research papers and the best review papers from two years previous. The top papers in each category published in 2020 were chosen based on citation and download statistics gathered from 2021. The papers were then voted on by...